Astera Labs (NASDAQ:ALAB) Trading 7.1% Higher – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB) traded up 7.1% on Thursday . The company traded as high as $113.86 and last traded at $113.9090. 1,278,462 shares were traded during mid-day trading, a decline of 75% from the average session volume of 5,113,501 shares. The stock had previously closed at $106.33.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
• Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
• Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
• Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
• Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
• Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)

Analyst Ratings Changes

ALAB has been the topic of several recent research reports. Citigroup started coverage on Astera Labs in a research note on Thursday. They issued a “buy” rating and a $200.00 price target on the stock. Royal Bank Of Canada began coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price objective for the company. Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Barclays set a $165.00 target price on Astera Labs in a research note on Thursday, January 15th. Finally, Northland Securities raised their price target on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Fifteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $199.44.

Astera Labs Price Performance

The firm has a market cap of $20.06 billion, a P/E ratio of 96.02, a price-to-earnings-growth ratio of 2.31 and a beta of 1.78. The firm has a fifty day moving average of $131.56 and a 200-day moving average of $159.64.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the sale, the director directly owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the sale, the chief financial officer directly owned 192,083 shares in the company, valued at $23,781,796.23. This trade represents a 5.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 577,292 shares of company stock worth $69,495,249 in the last quarter. 12.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Assetmark Inc. raised its holdings in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the period. Reflection Asset Management acquired a new position in Astera Labs during the fourth quarter worth approximately $25,000. Smartleaf Asset Management LLC increased its position in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank raised its stake in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Finally, Aventura Private Wealth LLC bought a new stake in Astera Labs in the fourth quarter valued at approximately $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.